Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Applying gastric residual volume as one of the indicators for enteral feeding intolerance: A scoping review.

Journal of the Intensive Care Society·2026

Same author

Life Years Gained and Healthcare Dollars Saved: National Economic Evidence Supporting Comprehensive Genomic Profiling as Standard of Care for Canadian Cancer Patients.

Current oncology (Toronto, Ont.)·2026

Same author

Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab.

NPJ precision oncology·2026

Same author

B cells drive CD4 T cell immunosenescence and age-associated health decline.

Science immunology·2026

Same author

Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Same author

Coordinate tumor-antigen uptake and dendritic cell activation by chimeric antigen receptors.

Science translational medicine·2025

Search research articles

Related Experiment Video

Updated: May 6, 2026

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Mobilizing and evaluating anticancer T cells: pitfalls and solutions.

Céline Robert-Tissot¹, Linh T Nguyen, Pamela S Ohashi

¹Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 2C1, Canada.

Expert Review of Vaccines

|October 17, 2013

Summary

Immunotherapy shows promise for fighting cancer by enhancing antitumor T cells. This review addresses challenges and offers solutions to improve T-cell therapy efficacy and clinical trial design for better cancer treatment outcomes.

More Related Videos

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Experiment Videos

Last Updated: May 6, 2026

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Area of Science:

Oncology
Immunology
Cancer Research

Background:

Immunotherapy is a leading strategy in cancer treatment, focusing on enhancing the body's immune response against malignant cells.
Antitumor T cells are critical mediators of adaptive immunity against cancer, and their function is a primary target for immunotherapeutic interventions.
While current strategies show clinical promise, significant challenges remain in fully realizing immunotherapy's potential.

Purpose of the Study:

To critically review existing methodologies for assessing T-cell responses in cancer immunotherapy.
To identify key challenges and propose solutions for improving the mobilization and therapeutic efficacy of antitumor T cells.
To provide recommendations for optimizing the design and analysis of future clinical trials and research specimens.

Main Methods:

Literature review and critical analysis of current immunotherapy research.
Evaluation of methodologies for characterizing T-cell responses in vitro and in vivo.
Synthesis of findings to propose improvements for clinical trial design and specimen analysis.

Main Results:

Discrepancies exist between in vitro T-cell measurements and in vivo protective responses, highlighting a gap in current assessment methods.
Several pitfalls in mobilizing antitumor T cells can limit therapeutic efficacy.
Optimized methodologies and careful analysis of clinical specimens are crucial for advancing immunotherapy.

Conclusions:

Addressing challenges in T-cell mobilization and response characterization is essential for enhancing cancer immunotherapy.
Improved experimental designs and analytical approaches will lead to more effective T-cell-based cancer treatments.
This review offers a framework for optimizing future clinical trials and research in cancer immunotherapy.